Skip to main content

  • Endovascular Intravascular Lithotripsy in the Treatment of Calcific Common Femoral Artery Disease: A Case Series With an 18-Month Follow-Up

    • Posted: 10/01/2022
    • Author:

      Muhammad Baig, Michael Kwok, Ammer Aldairi, Hafiz M. Imran, Mohammad S. Khan, Abdelmoniem Moustafa, Omar N. Hyder, Marwan Saad, Herbert D. Aronow and Peter A. Soukas

    • CRM2022

    Abstract

    Background

    Intravascular lithotripsy (IVL) is a novel endovascular treatment for calcified common femoral artery disease (CFA). Data on midterm effectiveness for clinically driven target lesions revascularization (CD-TLR) is lacking. This study investigated CD-TLR during 18-month follow-up in patients requiring IVL for CFA disease treatment.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details